Considering innate CD8 T-cells, our laboratory has observed a trend toward increased frequency in the bone marrow from patients at multiple myeloma diagnosis, suggesting their involvement in disease control (unpublished data). The gene discussed is CD8A; the disease is AL amyloidosis.